Vyne Therapeutics Inc (NASDAQ:VYNE)

0.28
BATS BZX Real-Time Price
As of 9:53am ET
 +0.0156 / +5.90%
Today’s Change
0.11
Today|||52-Week Range
0.79
+86.67%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-4.6M-14.1M-29.1M-51.4M
 
 
 
 
 
Depreciation0.004.0K8.0K22.0K
 
 
 
 
Total Other Cash Flow65.0K705.0K1.5M2.9M
 
 
 
 
 
Funds From Operations-4.5M-13.4M-27.5M-48.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-360.0K-11.1M722.0K4.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.2M-2.3M-28.2M-52.7M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-55.3M-64.1M-126.7M
 
 
 
 
Decrease In Investments0.0017.9M49.1M93.0M
 
 
 
 
Capital Expenditures0.00-31.0K-27.0K-140.0K
 
 
 
 
Net Cash Flow Investing0.00-37.5M-15.1M-33.9M
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale47.7M0.0050.4M125.9M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.00867.0K0.00
 
 
Net Cash Flow - Financing47.7M0.0049.5M125.9M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash43.5M-39.8M6.2M39.3M